2022.11.10
When multiple pathogens strike, are you still 1+1+1+1? The fast detection method is here!
The cold dew has passed, the temperature has dropped significantly in recent days, and the annual flu has also hit again. In the face of this familiar and unfamiliar "friend", how we prevent and control respiratory infectious diseases represented by COVID-19 and influenza is a threat that the world faces in recent years.
The cold dew has passed, the temperature has dropped significantly in recent days, and the annual flu has also hit again. In the face of this familiar and unfamiliar "friend", how we prevent and control respiratory infectious diseases represented by COVID-19 and influenza is a threat that the world faces in recent years.
With the constant enrichment, updating and iteration of pathogen detection methods, "how to better combine clinical judgment and detection methods to jointly provide assistance for the prevention, control and diagnosis and treatment of respiratory tract infections" has also become a topic worthy of deep consideration.
Related News
2022.11.10
Science: Major breakthrough! The copyright of the one-time multiple nucleic acid detection platform developed by Zhang Feng's team based on CRISPR belongs to the author.
In a new study, a rapid and cheap highly sensitive CRISPR based diagnostic tool - SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCK) was developed for the first time. The researchers greatly enhanced the function of this tool and developed a micro strip test method, which allows the naked eye to observe the test results without using expensive equipment. Relevant research results were published online in Science on February 15, 2018, with the title of "Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6".
Details
2022.11.10
Where are the investment opportunities behind nucleic acid testing?
If the genetic material of the virus, nucleic acid, can be found in the human body, it is undoubtedly the conclusive evidence that the person is infected. Since the outbreak of COVID-19 pneumonia, nucleic acid detection kits have replaced traditional medical images and become the final barrier between confirmed patients and suspected patients.
Details
